Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #44,151 to #44,200.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Anterior spinal veins (2 revisions)
  2. Anterior superior alveolar arteries (2 revisions)
  3. Anterior tibial artery (2 revisions)
  4. Anterior tibial recurrent artery (2 revisions)
  5. Anterior tympanic artery (2 revisions)
  6. Anterior ulnar recurrent artery (2 revisions)
  7. Anterolateral central arteries (2 revisions)
  8. Anthelmintic (2 revisions)
  9. Anthocyans (2 revisions)
  10. Anthony Adducci (2 revisions)
  11. Anthracycline (2 revisions)
  12. Anthrax surgey (2 revisions)
  13. Anthropometry (2 revisions)
  14. Anthroposophical medicine (2 revisions)
  15. Anti-Müllerian hormone receptor (2 revisions)
  16. Anti-neutrophil cytoplasmic antibody (2 revisions)
  17. Anti-smooth muscle antibody (2 revisions)
  18. Antianalgesia (2 revisions)
  19. Antiandrogen (2 revisions)
  20. Antiangiogenic (2 revisions)
  21. Antibiotic sensitivity (2 revisions)
  22. Antibody-Directed Enzyme Prodrug Therapy (2 revisions)
  23. Anticholinergic (2 revisions)
  24. Anticoagulation in patients with dilated cardiomyopathy (2 revisions)
  25. Anticonvulsant (2 revisions)
  26. Antidiarrhoeal (2 revisions)
  27. Antiemetic (2 revisions)
  28. Antifibrinolytic (2 revisions)
  29. Antifreeze (2 revisions)
  30. Antifungal drug (2 revisions)
  31. Antigen-presenting cell vaccine (2 revisions)
  32. Antimitochondrial antibodies (2 revisions)
  33. Antimony pentafluoride (2 revisions)
  34. Antimony pentasulfide (2 revisions)
  35. Antimycin A (2 revisions)
  36. Antineoplastic (2 revisions)
  37. Antineoplaston (2 revisions)
  38. Antinuclear antibodies (2 revisions)
  39. Antiprotozoal agent (2 revisions)
  40. Antipruritic (2 revisions)
  41. Antisense RNA (2 revisions)
  42. Antiseptic (2 revisions)
  43. Antiserum (2 revisions)
  44. Antispasmodic (2 revisions)
  45. Antistaphylococcal penicillins (2 revisions)
  46. Antistreptolysin O titer (2 revisions)
  47. Antithrombin III deficiency case study one (2 revisions)
  48. Antithrombin III deficiency classification (2 revisions)
  49. Antithrombin III deficiency cost-effectiveness of therapy (2 revisions)
  50. Antithrombin III deficiency future or investigational therapies (2 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)